about
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.Identifying postoperative atrial fibrillation in cardiac surgical patients posthospital discharge, using iPhone ECG: a study protocol.Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm.Development and testing of innovative patient resources for the management of coronary heart disease (CHD): a descriptive studyThe mobile revolution--using smartphone apps to prevent cardiovascular disease.Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.Opportunistic screening to detect atrial fibrillation in Aboriginal adults in Australia.Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): A feasibility study.Participating in cardiac rehabilitation: a systematic review and meta-synthesis of qualitative data.Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke in an ambulant population aged >=65 years (SEARCH-AF stroke prevention study): a cross-sectional study protocolSleep disordered breathing in chronic heart failure.Testosterone treatment and risk of venous thromboembolism: population based case-control study.Stroke risk and antithrombotic strategies in atrial fibrillation.Statin Therapy and Cognition in Older People: What is the Evidence?The Word Heart Federation Roadmap for Nonvalvular Atrial Fibrillation.Late follow-up (41 to 102 months) of medically treated patients with coronary artery spasm and minor atherosclerotic coronary obstructions.Planning locally relevant Internet programs for secondary prevention of cardiovascular disease.Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes.Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013.Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation.Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary prevention.Screening for Atrial Fibrillation Using a Smartphone: Is There an App for That?C-reactive protein contributes to the hypercoagulable state in coronary artery disease.Hypertriglyceridaemia is associated with early non-patency of coronary bypass grafts.Impact of medical consultation frequency on modifiable risk factors and medications at 12 months after acute coronary syndrome in the CHOICE randomised controlled trial.iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke.Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.Risk of adverse outcome in patients admitted to the coronary care unit with suspected unstable angina pectoris.Medical graduates becoming rural doctors: rural background versus extended rural placement.Fog on the crystal ball? Missing atrial fibrillation in forecasting the future of stroke.Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial.Prospective evaluation of the impact of diabetes and left ventricular hypertrophy on the relationship between ischemia and transient ischemic dilation of the left ventricle on single-day adenosine Tc-99m myocardial perfusion imaging.Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice.Low utilisation of cardiovascular risk reducing therapy in patients with acute coronary syndromes and non-obstructive coronary artery disease.Cardiac troponin-T and the prediction of acute and long-term mortality after acute pulmonary embolism.Choice of Health Options in Prevention of Cardiovascular Events (CHOICE) Replication Study.Choice of Health Options In prevention of Cardiovascular Events for people with Atrial Fibrillation (CHOICE-AF): A pilot study.Impact of sleep disordered breathing severity on hemodynamics, autonomic balance and cardiopulmonary functional status in chronic heart failure.
P50
Q30234524-E4CFE3A7-4524-40A3-965D-44E3412CDBBDQ30616300-ECC3C33F-4DE2-4E20-9AAF-09354520AD0FQ33172939-5376CB86-F9AE-45DC-88C7-A3AD39FD62C2Q33252927-B01E0BFD-109D-4604-8D10-A8981E225660Q33443067-54A94033-3AA9-4283-9DD2-F135C76015E7Q33444442-7FF1FA02-9DA2-4C4D-B06B-10E0A08C8E8EQ33451503-01DFB923-13BF-42FA-82B3-272D1A8F2727Q33451647-0AAE9A17-BC38-49F2-895C-8ADE0E245DE6Q34332051-8ED59165-A040-4DA9-9CAE-2E4EB64246AEQ34793416-08734A66-CB0E-46DA-8B86-AD34BEE53CD2Q35723642-309B163B-D1D6-4299-813C-3B32C954BD06Q36060854-456DA11E-970B-4423-B107-58EEE7874FB0Q37189457-6FCB67C4-3385-4934-BBD9-BA8EC77F3668Q37459112-71D3176D-8259-4177-93AA-E3E5975ACF39Q37798629-EC477A38-C750-4501-A637-89463763E7F8Q38580466-EDE76F1F-4C09-41FA-A42B-9EDCA67ADEF3Q39197308-90CEC3AA-18C2-44AD-9A8D-A892C08BC0B6Q39790265-9946CCDC-4411-4D5D-AA19-C560B3D6586CQ39841786-76B2CA7F-EC38-456B-900D-6A2CE755E590Q39969575-F8880565-2874-4F03-824A-974C8485B050Q40607580-CDB19301-5328-45DF-9B41-88A28787BFF4Q40641454-01B7A540-D206-465B-992E-FBD22930602FQ40821191-A65E95E2-04B2-4193-9D83-9A6BC6BC1CF3Q42397077-57A47378-C466-406E-B3D1-65556DCAFDAEQ42489262-49297B19-B1A5-4701-9F4F-8E44D837F008Q42832344-31BC9156-6C35-4745-8952-A565B04B4915Q43073260-E4ABFC21-D899-4E28-98F5-6AE887928407Q44825185-03F38245-B81C-443E-96D2-77699A9AA4E4Q44973053-8C64A829-761A-4480-9056-8F5A5231CA08Q45027423-18444F58-08C3-4AE1-9716-8547591D2D52Q45225513-DC6B9E3B-3FEC-499F-8BBA-17DE05C1A90EQ45924202-75AC4B01-6A12-41D6-9108-CC646B37C80BQ46100884-E69E17D7-B792-4856-955F-04D72D87B0AEQ46399266-868953B2-F53C-4BBA-9B76-03ED16694A9DQ46638741-838D3D78-C7B0-4597-B1EC-D9F7BE45C2FCQ46736878-7CC8BD6B-EB93-404B-AD51-EB5BA6B9E9A9Q46737709-2BEE922F-E3B7-4D95-B9B6-5FC8713D60ADQ47628388-420E93D9-8410-4B16-8DF5-B5C630A75105Q48066338-FDE34F39-6276-4BED-8B32-FCFAD3DD24BDQ48412819-090F7BBD-05DE-418C-B616-A1D90D308822
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ben Freedman
@ast
Ben Freedman
@en
Ben Freedman
@es
Ben Freedman
@nl
Ben Freedman
@sl
type
label
Ben Freedman
@ast
Ben Freedman
@en
Ben Freedman
@es
Ben Freedman
@nl
Ben Freedman
@sl
prefLabel
Ben Freedman
@ast
Ben Freedman
@en
Ben Freedman
@es
Ben Freedman
@nl
Ben Freedman
@sl
P1053
C-1625-2013
P106
P21
P31
P3829
P496
0000-0002-3809-2911